tnt009
mAbexperimental
Clinical trial activity
1 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2015 (NCT02502903)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Complement C1sINHIBITOR
C1S inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- tnt009
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02502903 | Phase 1 | Jun 1, 2015 | ABF Pharmaceutical Services GmbH, Assign Clinical Research GmbH, Quest Diagnostics, True North Therapeutics, University of Vienna, Vela Laboratories |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ABF Pharmaceutical Services GmbH | For profit | 1 | 0 | 1 | 2015 |
| Assign Clinical Research GmbH | For profit | 1 | 0 | 1 | 2015 |
| Quest Diagnostics | For profit | 1 | 0 | 1 | 2015 |
| True North Therapeutics | For profit | 1 | 1 | 1 | 2015 |
| University of Vienna | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Vela Laboratories | For profit | 1 | 0 | 1 | 2015 |
6 organizations
Page 1 / 1